Home›People›Omead Ostadan
Omead Ostadan

Omead Ostadan

CEO, Board Member at Cellanome.

ExecutiveDirectorPublic company
Updated Nov 10, 2026·Latest SEC filing Jun 22, 2026·Suggest an edit

About Omead Ostadan

Omead Ostadan is CEO, Board Member at Cellanome.

Omead Ostadan reports to the SEC as a director or officer of 2 public companies: Seer (SEER) and Illumina (ILMN).

Omead Ostadan first appears on SEC filings in 2015.

Experience

This experience comes from Omead Ostadan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Omead Ostadan in the role, so the role may have started earlier or lasted longer.

Cellanome, Inc. Current
CEO, Board Member
President and CEO (2023 – Present)
2021 – Present · Foster City, CA
Cellanome makes a live-cell analysis platform for biological researchers.
Seer, Inc.
President and COO (2020 – 2022)
Director
2020 – 2022 · Public company (SEER)
Illumina, Inc.
SVP Mktg, Prod & Strat Plan
Senior Vice President, Products, Marketing and Strategic Planning (2007 – 2020)
2007 – 2020 · Public company (ILMN)

Key Colleagues at Startups

The people Omead Ostadan works with at each company, as listed on that company's latest Form D.

Cellanome, Inc. · Form D, Jun 22, 2026
MK
Mostafa Ronaghi
Mostafa Ronaghi
Cofounder, Executive Board Member
SP
Sandesh Patnam
Board Member
Rowan Chapman
Rowan Chapman
Board Member
Jay Flatley
Jay Flatley
Chairman

Sources

  1. SECCellanome, Inc. Form D, filed Jun 22, 2026
  2. SECForms 3, 4 and 5 filed by Omead Ostadan (SEC filer 1642678)